Laura Sepp-lorenzino - Net Worth and Insider Trading
Laura Sepp-lorenzino Net Worth
The estimated net worth of Laura Sepp-lorenzino is at least $532,395 dollars as of 2024-12-26. Laura Sepp-lorenzino is the EVP, Chief Scientific Officer of Intellia Therapeutics Inc and owns about 43,927 shares of Intellia Therapeutics Inc (NTLA) stock worth over $532,395. Details can be seen in Laura Sepp-lorenzino's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Laura Sepp-lorenzino has not made any transactions after 2024-01-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Laura Sepp-lorenzino
Laura Sepp-lorenzino Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Laura Sepp-lorenzino owns 2 companies in total, including Intellia Therapeutics Inc (NTLA) , and Taysha Gene Therapies Inc (TSHA) .
Click here to see the complete history of Laura Sepp-lorenzino’s form 4 insider trades.
Insider Ownership Summary of Laura Sepp-lorenzino
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NTLA | Intellia Therapeutics Inc | 2024-01-08 | EVP & Chief Scientific Officer |
TSHA | Taysha Gene Therapies Inc | 2020-11-23 | director |
Laura Sepp-lorenzino Latest Holdings Summary
Laura Sepp-lorenzino currently owns a total of 1 stock. Laura Sepp-lorenzino owns 43,927 shares of Intellia Therapeutics Inc (NTLA) as of January 8, 2024, with a value of $532,395.
Latest Holdings of Laura Sepp-lorenzino
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
NTLA | Intellia Therapeutics Inc | 2024-01-08 | 43,927 | 12.12 | 532,395 |
Holding Weightings of Laura Sepp-lorenzino
Laura Sepp-lorenzino Form 4 Trading Tracker
According to the SEC Form 4 filings, Laura Sepp-lorenzino has made a total of 6 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 2,275 shares on January 8, 2024, which brought Laura Sepp-lorenzino around $65,679.
Insider Trading History of Laura Sepp-lorenzino
- 1
Laura Sepp-lorenzino Trading Performance
Laura Sepp-lorenzino Ownership Network
Laura Sepp-lorenzino Owned Company Details
What does Intellia Therapeutics Inc do?
Who are the key executives at Intellia Therapeutics Inc?
Laura Sepp-lorenzino is the EVP & Chief Scientific Officer of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Technical Officer Eliana Clark , EVP & Chief Business Officer Derek Hicks , and director & President and CEO John M. Leonard .
Intellia Therapeutics Inc (NTLA) Insider Trades Summary
Over the past 18 months, Laura Sepp-lorenzino made 2 insider transaction in Intellia Therapeutics Inc (NTLA) with a net sale of 7,807. Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 5,373 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 19,223 shares made by John M. Leonard .
In summary, during the past 3 months, insiders sold 2,012 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 2,012 shares. During the past 18 months, 57,207 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 57,207 shares.
Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intellia Therapeutics Inc Insider Transactions
Laura Sepp-lorenzino Mailing Address
Above is the net worth, insider trading, and ownership report for Laura Sepp-lorenzino. You might contact Laura Sepp-lorenzino via mailing address: C/o Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge Ma 02139.